Evidence map›Paper›PMID 37789148›Full record

ArticleLeukemia2023

Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.

Ekaterina Jahn, Maral Saadati, Pierre Fenaux, Marco Gobbi, Gail J Roboz, Lars Bullinger, Pavlo Lutsik, Anna Riedel, Christoph Plass, Nikolaus Jahn and 11 more

Abstract readPublished Erratum
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Ekaterina JahnDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0009-0001-0741-1166
Maral SaadatiSaadati Solutions, Ladenburg, Germany.
Pierre FenauxHôpital Saint-Louis, Paris, France.
Marco GobbiOspedale Policlinico San Martino, Genova, Italy.
Gail J RobozWeill Cornell Medicine, New York, NY, USA.
Lars BullingerDepartment of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Pavlo LutsikDepartment of Oncology, Catholic University (KU) Leuven, Leuven, Belgium.
Anna RiedelDivision of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.
Christoph PlassDivision of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-2554-3952
Nikolaus JahnDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Claudia WalterDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Karlheinz HolzmannGenomics Core Facility, Medical Faculty, Ulm University, Ulm, Germany.
Yong HaoAstex Pharmaceuticals, Inc., Pleasanton, CA, USA.
Sue NaimAstex Pharmaceuticals, Inc., Pleasanton, CA, USA.
Nicholas SchreckDivision of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Julia KrzykallaDivision of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Axel BennerDivision of Biostatistics, German Cancer Research Center, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-7238-6956
Harold N KeerAstex Pharmaceuticals, Inc., Pleasanton, CA, USA.
Mohammad AzabAstex Pharmaceuticals, Inc., Pleasanton, CA, USA.
Konstanze Döhner *Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0002-2261-9862
Hartmut Döhner *Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany. hartmut.doehner@uniklinik-ulm.de.ORCID http://orcid.org/0000-0003-2116-5536

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37789148
PMCPMC10624611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.